Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-06

Clinical Trial Update: Clinical Study on the Safety and Effectiveness of Vagus Nerve Stimulation in the Treatment of Refractory Depression [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on safety and effectiveness of vagus nerve stimulation for refractory depression (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vagus nerve stimulation (vagus nerve stimulation)

Snippet

Sponsor: Xijing Hospital | Conditions: Refractory Depression | Phase 1, Phase 2 | Status: UNKNOWN